Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
Background Visual assessment of amyloid PET scans relies on the availability of radiologist expertis...
Neurodegenerative diseases, such as Alzheimer's disease, pose a significant global health challenge ...
STUDY OBJECTIVES: Isolated rapid eye movement sleep behavior disorder (iRBD) is a prodromal stage of...
Alzheimer's disease (AD) is a common and serious form of elderly dementia, but early detection and t...
BACKGROUND: Alzheimer's disease (AD) is an irreversible primary brain disease with insidious onset. ...
PURPOSE: Use of artificial intelligence (AI) in cancer care is increasing. What remains unclear is h...
Given the prevalence of dementia and the development of pathology-specific disease-modifying therapi...
Nursing staff record observations about older people under their care in free-text nursing notes. Th...
Dementia profoundly impacts patients and their families, making it essential to understand the exper...
Machine learning (ML) algorithms play a crucial role in the early and accurate diagnosis of Alzheime...
Alzheimer's disease (AD) manifests with varying progression rates across individuals, necessitating ...
OBJECTIVE: The objective of this study is to develop a more effective early detection system for Alz...
Purpose To present results from a literature survey on practices in deep learning segmentation algor...
BACKGROUND: Alzheimer's disease (AD), a major dementia cause, lacks effective treatment. MRI-based h...
BACKGROUND: Differentiation of high-flow from low-flow vascular malformations (VMs) is crucial for t...
BACKGROUND: The progressive cognitive decline, an integral component of Alzheimer's disease (AD), un...
BACKGROUND: The growing number of older adults in recent decades has led to more prevalent geriatric...
Alzheimer's disease (AD) is a chronic neurodegenerative disorder with a global impact. The past few ...
BACKGROUND: There are various molecular hypotheses regarding Alzheimer's disease (AD) like amyloid d...
BACKGROUND: Primary outcome measure in the clinical trials of disease modifying therapy (DMT) drugs ...
With the advent of therapeutics with potential to slow Alzheimer's disease progression the necessity...